Toshimi Tando

HIF1α is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis

P. Chambon, S. Kato, Y. Toyama, 2013, Proceedings of the National Academy of Sciences.

Hyperglycemia Promotes Schwann Cell De-differentiation and De-myelination via Sorbitol Accumulation and Igf1 Protein Down-regulation*

Y. Toyama, K. Miyamoto, T. Miyamoto, 2015, The Journal of Biological Chemistry.

Interleukin-1 Receptor-associated Kinase-4 (IRAK4) Promotes Inflammatory Osteolysis by Activating Osteoclasts and Inhibiting Formation of Foreign Body Giant Cells*

Y. Toyama, K. Miyamoto, T. Miyamoto, 2014, The Journal of Biological Chemistry.

A serum metabolomics-based profile in low bone mineral density postmenopausal women.

M. Tomita, Y. Toyama, T. Soga, 2017, Bone.

Smad2/3 Proteins Are Required for Immobilization-induced Skeletal Muscle Atrophy*

M. Tomita, A. Yoshimura, Y. Toyama, 2016, The Journal of Biological Chemistry.

Bcl6 promotes osteoblastogenesis through Stat1 inhibition.

Y. Toyama, K. Miyamoto, T. Miyamoto, 2015, Biochemical and biophysical research communications.

Methotrexate inhibits osteoclastogenesis by decreasing RANKL-induced calcium influx into osteoclast progenitors

H. Saya, Y. Toyama, K. Miyamoto, 2016, Journal of Bone and Mineral Metabolism.

Hif1α is required for osteoclast activation and bone loss in male osteoporosis.

Y. Toyama, K. Miyamoto, T. Miyamoto, 2016, Biochemical and biophysical research communications.